Speaker(s): 

Vrunda Mangaroliya, MD, Internal Medicine Resident, Staff Member, Geisinger - has nothing to disclose.

Moderator(s): 

Connor Dougherty, DO, Staff Member, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Discuss epidemiology of primary IgA nephropathy
• Discuss clinical features, pathophysiology and prognosis of primary IgAN
• Review current KDIGO guidelines for primary IgAN
• Discuss Newer treatment options and trials

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Conner Dougherty, DO; Karlyn Paglia, MD; Juan R. Escobar, MD; Shashank Kotakonda, MD; Jayalakshmi Nair, MD; Jignesh Patel, MD; Jameson Woodard, MD; Hasan Zerti, MD and Eric Drago, MD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant.